BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20556588)

  • 1. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
    Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
    Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.
    Zheng JN; Sun YF; Pei DS; Liu JJ; Chen JC; Li W; Sun XQ; Shi QD; Han RF; Ma TX
    Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):500-6. PubMed ID: 16820866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
    Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
    Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference.
    Miri-Moghaddam E; Deezagi A; Soheili ZS
    Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3.
    Tan J; Zhou X; Zhu H
    Exp Clin Transplant; 2012 Aug; 10(4):386-93. PubMed ID: 22757972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasmid-mediated RNAi targeting hTERT inhibits telomerase activity in K562 cell line].
    Li MF; Fang MY; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):54-60. PubMed ID: 18315900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective siRNA targets screening for human telomerase reverse transcriptase.
    Xia Y; Lin RX; Zheng SJ; Yang Y; Bo XC; Zhu DY; Wang SQ
    World J Gastroenterol; 2005 Apr; 11(16):2497-501. PubMed ID: 15832425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective inhibition of hTERT expression by RNA interference on the radiosensitivity of human laryngeal cancer Hep-2 cell line].
    Qiu HB; Zhou YF; Zhou FX; Xie CH; Luo ZG; Yu HJ; Liu SQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):9-13. PubMed ID: 17575685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
    Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
    Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
    Kurvinen K; Syrjänen S; Johansson B
    Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
    Kamradt J; Drosse C; Kalkbrenner S; Rohde V; Lensch R; Lehmann J; Fixemer T; Bonkhoff H; Stoeckle M; Wullich B
    Lab Invest; 2003 May; 83(5):623-33. PubMed ID: 12746472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo.
    Xie M; Chen Q; He S; Li B; Hu C
    Oncol Rep; 2011 Oct; 26(4):1019-27. PubMed ID: 21743972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of adenovirus expressing siRNA against hTR and its anti-tumor activity in vitro].
    Li Y; Xiao LY; Yao G; Li H; Yang ZW; Li WY; Jiang ZH; Li MY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):570-3. PubMed ID: 18538086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.